Influence of Duffy blood type on hydroxyurea (HU) therapy in pediatric sickle cell disease (SCD) patients.

被引：0
|
作者：
Raphael, R [1 ]
OheneFrempong, K [1 ]
Horiuchi, K [1 ]
机构：
[1] UNIV PENN,CHILDRENS HOSP PHILADELPHIA,DEPT PEDIAT,PHILADELPHIA,PA 19104
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1972 / 1972
页数：1
相关论文
共 50 条
  • [1] Hydroxyurea (HU) therapy improves cognitive functioning in sickle cell disease (SCD) patients.
    Bernaudin, F
    Freard, F
    Lesprit, E
    Roudot-Thoraval, F
    Verlhac, S
    Benkerrou, M
    Thuret, I
    Mardini, R
    Vannier, JP
    Ploix, E
    Romero, M
    Casse-Perrot, C
    Helly, M
    Gillard, E
    Brugieres, P
    Reinert, P
    BLOOD, 1999, 94 (10) : 416A - 417A
  • [2] Role of hydroxyurea (HU) in children with sickle cell disease (SCD)
    Motwani, J
    Lawson, SE
    Darbyshire, PJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 24 - 25
  • [3] Prevention of stroke recurrence with blood transfusions followed by hydroxyurea (HU) in patients with sickle cell disease (SCD)
    Aygun, B
    Moore, JW
    Karayalcin, G
    PEDIATRIC RESEARCH, 2003, 53 (04) : 293A - 294A
  • [4] Prevention of stroke recurrence with blood transfusions followed by hydroxyurea (HU) in patients with sickle cell disease (SCD)
    Aygun, B
    Moore, JW
    Karayalcin, G
    BLOOD, 2002, 100 (11) : 28B - 28B
  • [5] Citrate Synthase Activity Is Increased In Children With Sickle Cell Disease (SCD) On Hydroxyurea (HU) Therapy
    Morris, Claudia R.
    Latronica, Cornelia
    Kuypers, Frans A.
    Rosenfeld, Howard
    Larkin, Sandra K.
    Doniger, Stephanie
    Vichinsky, Elliott
    Shiva, Sruti
    BLOOD, 2013, 122 (21)
  • [6] Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?
    Galacteros, Frederic
    Voskaridou, Ersi
    Habibi, Anoosha
    Cannas, Giovanna
    Joseph, Laure
    Loko, Gylna
    De Montalembert, Mariane
    Elenga, Narcisse
    Benkerrou, Malika
    BLOOD, 2020, 136
  • [7] Chronic Administration of Hydroxyurea (HU) and Outcomes in Patients with Sickle Cell Disease (SCD) at a Single Referral Institution
    Di Maggio, Rosario
    Hsieh, Matthew
    Fitzhugh, Courtney
    Zhao, Xiongce
    Calvaruso, Giusi
    Rigano, Paolo
    Renda, Disma
    Siragusa, Sergio
    Tisdale, John F.
    Maggio, Aurelio
    BLOOD, 2014, 124 (21)
  • [8] Documenting the effectiveness of hydroxyurea (HU) to treat sickle cell disease (SCD) in the community setting
    Lanzkron, Sophie
    Haywood, Carlton, Jr.
    Fagan, Peter
    BLOOD, 2007, 110 (11) : 291A - 291A
  • [9] Duffy Antigen Status, Hydroxyurea Dosing, and Phenotype Severity in Pediatric Patients with Sickle Cell Disease
    Celello, Alison
    Mckinney, Christopher
    BLOOD, 2024, 144 : 5336 - 5336
  • [10] Hydroxyurea in children with sickle cell disease (SCD).
    Olivieri, NF
    Basran, R
    NisbetBrown, E
    Blanchette, N
    Styles, L
    Talbot, A
    Das, M
    HackneyStephens, E
    Kleman, K
    Vichinsky, EP
    BLOOD, 1996, 88 (10) : 2473 - 2473
12345